Cargando…
Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers
Nanomaterials providing sustained release profiles are highly desired for efficacious drug delivery. Advanced nanotechnologies are useful tools for creating elaborate nanostructure-based nanomaterials to achieve the designed functional performances. In this research, a modified coaxial electrospinni...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923514/ https://www.ncbi.nlm.nih.gov/pubmed/29565280 http://dx.doi.org/10.3390/nano8040184 |
_version_ | 1783318359327113216 |
---|---|
author | Liu, Xinkuan Shao, Wenyi Luo, Mingyi Bian, Jiayin Yu, Deng-Guang |
author_facet | Liu, Xinkuan Shao, Wenyi Luo, Mingyi Bian, Jiayin Yu, Deng-Guang |
author_sort | Liu, Xinkuan |
collection | PubMed |
description | Nanomaterials providing sustained release profiles are highly desired for efficacious drug delivery. Advanced nanotechnologies are useful tools for creating elaborate nanostructure-based nanomaterials to achieve the designed functional performances. In this research, a modified coaxial electrospinning was explored to fabricate a novel core-sheath nanostructure (nanofibers F2), in which a sheath drug-free gliadin layer was successfully coated on the core ketoprofen (KET)-gliadin nanocomposite. A monolithic nanocomposite (nanofibers F1) that was generated through traditional blending electrospinning of core fluid was utilized as a control. Scanning electron microscopy demonstrated that both nanofibers F1 and F2 were linear. Transmission electron microscopy verified that nanofibers F2 featured a clear core-sheath nanostructure with a thin sheath layer about 25 nm, whereas their cores and nanofibers F1 were homogeneous KET-gliadin nanocomposites. X-ray diffraction patterns verified that, as a result of fine compatibility, KET was dispersed in gliadin in an amorphous state. In vitro dissolution tests demonstrated that the thin blank nanocoating in nanofibers F2 significantly modified drug release kinetics from a traditional exponential equation of nanofibers F1 to a zero-order controlled release model, linearly freeing 95.7 ± 4.7% of the loaded cargoes over a time period of 16 h. |
format | Online Article Text |
id | pubmed-5923514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59235142018-05-03 Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers Liu, Xinkuan Shao, Wenyi Luo, Mingyi Bian, Jiayin Yu, Deng-Guang Nanomaterials (Basel) Article Nanomaterials providing sustained release profiles are highly desired for efficacious drug delivery. Advanced nanotechnologies are useful tools for creating elaborate nanostructure-based nanomaterials to achieve the designed functional performances. In this research, a modified coaxial electrospinning was explored to fabricate a novel core-sheath nanostructure (nanofibers F2), in which a sheath drug-free gliadin layer was successfully coated on the core ketoprofen (KET)-gliadin nanocomposite. A monolithic nanocomposite (nanofibers F1) that was generated through traditional blending electrospinning of core fluid was utilized as a control. Scanning electron microscopy demonstrated that both nanofibers F1 and F2 were linear. Transmission electron microscopy verified that nanofibers F2 featured a clear core-sheath nanostructure with a thin sheath layer about 25 nm, whereas their cores and nanofibers F1 were homogeneous KET-gliadin nanocomposites. X-ray diffraction patterns verified that, as a result of fine compatibility, KET was dispersed in gliadin in an amorphous state. In vitro dissolution tests demonstrated that the thin blank nanocoating in nanofibers F2 significantly modified drug release kinetics from a traditional exponential equation of nanofibers F1 to a zero-order controlled release model, linearly freeing 95.7 ± 4.7% of the loaded cargoes over a time period of 16 h. MDPI 2018-03-22 /pmc/articles/PMC5923514/ /pubmed/29565280 http://dx.doi.org/10.3390/nano8040184 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Xinkuan Shao, Wenyi Luo, Mingyi Bian, Jiayin Yu, Deng-Guang Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers |
title | Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers |
title_full | Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers |
title_fullStr | Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers |
title_full_unstemmed | Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers |
title_short | Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers |
title_sort | electrospun blank nanocoating for improved sustained release profiles from medicated gliadin nanofibers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923514/ https://www.ncbi.nlm.nih.gov/pubmed/29565280 http://dx.doi.org/10.3390/nano8040184 |
work_keys_str_mv | AT liuxinkuan electrospunblanknanocoatingforimprovedsustainedreleaseprofilesfrommedicatedgliadinnanofibers AT shaowenyi electrospunblanknanocoatingforimprovedsustainedreleaseprofilesfrommedicatedgliadinnanofibers AT luomingyi electrospunblanknanocoatingforimprovedsustainedreleaseprofilesfrommedicatedgliadinnanofibers AT bianjiayin electrospunblanknanocoatingforimprovedsustainedreleaseprofilesfrommedicatedgliadinnanofibers AT yudengguang electrospunblanknanocoatingforimprovedsustainedreleaseprofilesfrommedicatedgliadinnanofibers |